A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM)

被引：0
|
作者：
Leone, Jose Pablo
Hu, Jiani
Barry, William Thomas
Duda, Dan G.
Gerstner, Elizabeth Robins
Jain, Rakesh K.
Tan, Sally
Lawler, Elizabeth S.
Winer, Eric P.
Lin, Nancy U.
Tolaney, Sara M.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC)
    Barroso-Sousa, Romualdo
    Trippa, Lorenzo
    Li, Tianyu
    Keenan, Tanya E.
    Winship, Grace
    Andrews, Chelsea
    Osmani, Wafa
    Overmoyer, Beth
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Duda, Dan G.
    Tolaney, Sara M.
    CANCER RESEARCH, 2020, 80 (04)
  • [42] A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2-metastatic breast cancer (MBC).
    Anders, Carey K.
    Le Rhun, Emilie
    Bachelot, Thomas Denis
    Yardley, Denise A.
    Awada, Ahmad
    Conte, Pier Franco
    Kabos, Peter
    Bear, Melissa
    Yang, Zhengyu
    Chen, Yanyun
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with metastatic, human epidermal growth factor receptor 2-positive breast cancer
    Freedman, Rachel A.
    Luis, Ines Maria Vaz Duarte
    Barry, William Thomas
    Krop, Ian E.
    Wagle, Nikhil
    Lowe, Alarice
    Galler, Sarah
    Sohl, Jessica
    Isakoff, Steven J.
    Tung, Nadine M.
    Winer, Eric P.
    Lin, Nancy U.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM)
    Schvartsman, Gustavo
    Glitza, Isabella Claudia
    Milton, Denai
    Amaria, Rodabe Navroze
    Hwu, Patrick
    Hwu, Wen-Jen
    Diab, Adi
    Wong, Michael K. K.
    Patel, Sapna Pradyuman
    Wefel, Jeffrey Scott
    Burton, Elizabeth M.
    Brown, Courtney
    Woodman, Scott Eric
    Beosch, Ingrid M.
    Chung, Caroline
    Davies, Michael A.
    Tawbi, Hussein Abdul-Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Whole Brain Radiotherapy with Concurrent Trastuzumab for Treatment of Brain Metastases in Breast Cancer Patients
    Idrissi, H. Riahi
    Chargari, C.
    Pierga, J.
    Bollet, M.
    Dieras, V.
    Campana, F.
    Cottu, P.
    Fourquet, A.
    Kirova, Y. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S238 - S238
  • [46] Phase II study of trastuzumab in combination with capecitabine and oxaliplatin in patients with advanced gastric cancer
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Park, Young Soo
    Park, Sook Ryun
    Kim, Jong Gwang
    Han, Hye-Suk
    Chung, Ik-Joo
    Song, Eun-Kee
    Lee, Kyung Hee
    Kang, Seok Yun
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [47] A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.
    Wang, Jianbo
    Campbell, Matthew T.
    Shah, Amishi Yogesh
    Goswami, Sangeeta
    Msaouel, Pavlos
    Alhalabi, Omar
    Hahn, Andrew Warren
    Kovitz, Craig A.
    Jana, Bagi Rp
    Araujo, John C.
    Gao, Jianjun
    Zurita, Amado J.
    Jonasch, Eric
    Corn, Paul Gettys
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [48] Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
    Metzger Filho, O.
    Leone, J. P.
    Li, T.
    Tan-Wasielewski, Z.
    Trippa, L.
    Barry, W. T.
    Younger, J.
    Lawler, E.
    Walker, L.
    Freedman, R. A.
    Tolaney, S. M.
    Krop, I
    Winer, E. P.
    Lin, N. U.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1231 - 1239
  • [49] Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Ng, Mei R.
    Barry, William T.
    Higgins, Michaela J.
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena V.
    Paweletz, Cloud P.
    Demeo, Michelle K.
    Ramaiya, Nikhil H.
    Overmoyer, Beth A.
    Jain, Rakesh K.
    Winer, Eric P.
    Duda, Dan G.
    ONCOLOGIST, 2017, 22 (01): : 25 - 32
  • [50] TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+metastatic breast cancer (MBC)
    Lin, N. U.
    Mayer, I. A.
    Hobday, T. J.
    Falkson, C. I.
    Dees, E. C.
    Nanda, R.
    Krop, I. E.
    Rimawi, M. F.
    Wolff, A. C.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345